Does TILDRAKIZUMAB-ASMN Cause Needle issue? 7 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Needle issue have been filed in association with TILDRAKIZUMAB-ASMN. This represents 0.4% of all adverse event reports for TILDRAKIZUMAB-ASMN.
7
Reports of Needle issue with TILDRAKIZUMAB-ASMN
0.4%
of all TILDRAKIZUMAB-ASMN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Needle issue From TILDRAKIZUMAB-ASMN?
Of the 7 reports.
Is Needle issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TILDRAKIZUMAB-ASMN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TILDRAKIZUMAB-ASMN Cause?
Product dose omission issue (363)
Drug ineffective (223)
Psoriasis (86)
Death (84)
Product storage error (74)
Self-medication (74)
Off label use (66)
Condition aggravated (63)
Rash (54)
Pruritus (52)
What Other Drugs Cause Needle issue?
OCTREOTIDE (2,740)
GUSELKUMAB (1,933)
USTEKINUMAB (1,930)
EXENATIDE (1,821)
GOLIMUMAB (1,023)
ADALIMUMAB (1,022)
SOMATROPIN (981)
SECUKINUMAB (958)
ABATACEPT (716)
DUPILUMAB (686)
Which TILDRAKIZUMAB-ASMN Alternatives Have Lower Needle issue Risk?
TILDRAKIZUMAB-ASMN vs TILIDINE
TILDRAKIZUMAB-ASMN vs TIMOLOL
TILDRAKIZUMAB-ASMN vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB-ASMN vs TINIDAZOLE
TILDRAKIZUMAB-ASMN vs TINZAPARIN